Current guidelines recommend the use of low molecular weight heparin ( LMWH ) for most haemodynamically stable patients with pulmonary thromboembolism ( PTE ) , however , it is not clear whether LMWH is preferable to unfractionated heparin ( UFH ) for the treatment of massive PTE .